Rare diseases
Investigational molecules
Locations
346 conditions with trials, the busiest first
960 trials across Europe, recruiting first
Study on Irinotecan for Brain Metastases in Patients with HER2-Negative Breast Cancer
SpainStudy of Durvalumab and Tremelimumab for Patients with Colorectal and Endometrial Cancer
SpainStudy on the Safety and Effectiveness of LIB-01 for Treating Erectile Dysfunction in Adult Men
DenmarkStudy Comparing Carboplatin and Cisplatin for Patients with Extracranial Malignant Germ Cell Tumors
AustriaStudy on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
BelgiumStudy of mirvetuximab soravtansine compared to standard chemotherapy in women with platinum-resistant advanced ovarian cancer with high folate receptor expression
FranceStudy of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer
BelgiumStudy on the Effects of Durvalumab, Oleclumab, and Chemotherapy in Patients with Luminal B Breast Cancer
BelgiumStudy Comparing Oral Paclitaxel (DHP107) and IV Paclitaxel for Patients with Recurrent or Metastatic HER2 Negative Breast Cancer
HungaryStudy of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations
BelgiumStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
BelgiumStudy on Amcenestrant Alone and with Drug Combination for Postmenopausal Women with Estrogen Receptor-Positive Advanced Breast Cancer
BelgiumThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
